In this study, we evaluated the expression of DCLK1 in a large cohort of breast cancer by immunohistochemistry (IHC), its association with clinico-pathological features and other biomarkers (including CSC markers) expression, as well as the relationship with breast cancer outcome. This evidence concerns the gene DCLK1 and breast cancer.